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Abstract
Salmonella is a bacterium that can cause an illness in humans called salmonellosis. In the European Union, over 100,000 
human cases were reported last year. The EFSA has estimated that the overall economic cost of human salmonellosis could 
be as high as EUR 3 billion a year.
In the present study, Salmonella spp. analyses based on ISO 6579:2002, was derived as a part of a HACCP procedure in a 
meat processing company. From the four analyzed samples, dry cured sausage, black pudding, fresh sausage and meatloaf, 
Salmonella sp. was isolated in the last two samples. Both isolates were sent to the Portuguese Reference Laboratory for Sal-
monella (Instituto Nacional de Saúde Dr Ricardo Jorge – INSA) and serotyped according to the Kauffmann-White scheme. 
Salmonella Budapest was identified in both products. This result may indicate a common source of contamination for both 
products that may occurred in the production chain. Using rastreability data it was possible to observe that the meat used 
in both products was from national swine slaughtered in Portuguese abattoirs. According to data provided by INSA, until 
2012, besides these two Salmonella Budapest isolates, were only recorded two more cases isolated from sausage and frozen 
gizzards from Brazil.
With regard to Portuguese human data, in the last decade, there was five cases of S. enterica serovar Budapest infection that 
were related to gastroenteritis and only one associated with pyogenic skin lesion. This data suggests that we may be facing 
an isolated case of cross-contamination in the production line due to poor equipment hygiene throughout the chain. Addi-
tional studies are being made to understand dangerous strain with regard to virulence profile and antimicrobial resistance.
Introduction
Salmonella is a bacterium that can cause an illness in humans called salmonellosis. It is an almost universally accepted 
dogma that human salmonellosis is a zoonosis (1, 2, 3) and is a major cause of bacterial enteric illness in both humans and 
animals(4). A high percentage of Salmonella-positive samples of ground meat from swine (40.3%) and cattle (46%) and 
of processed poultry products (56.3%) implies that a consumer has a 50:50 chance of carrying home live Salmonella with 
these products from the supermarkets (5). Salmonella strains from food animals are passed to the human population via in-
sufficiently cooked meat, eggs, and milk (3). Since enteric infections with Salmonella in humans result in multiplication and 
excretion of the infectious agents in and from the human intestine, the animal-food-human spread must be regarded as 
an important contribution to the release of antibiotic-resistant bacteria from farm animals (6, 7). In 1997, the World Health 
Organization for the first time ever published a report on the medical impact of the use of antimicrobials in food animals(8). 
The main threats were formulated as: (a) an increase in the prevalence of resistant bacteria in animals; the transfer of re-
sistant pathogens to humans via direct contact with animals, or through the consumption of contaminated food or water; 
(b) the transfer of resistance to human bacteria; (c) an increase in the incidence of human infections caused by resistant 
pathogens; (d) potential therapeutic failures in animals and humans; and (e) frightening resistance situations in farm an-
imals regarding Salmonella, Campylobacter, Enterococcus species and E. coli. In these study was serotyped two strains of 
Salmonella Budapest according to the Kauffmann-White scheme, on the basis of serologic identification of O (somatic) and 
H (flagellar) antigens(9) and was made an antimicrobial resistance profile based on CLSI information. 
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Material and Methods
1. Sampling
Sampling procedure was done randomly during the HACCP actions in a butcher for resale area from one meat processing 
company. Four meat samples were analyzed: dry cured sausage, black pudding, fresh sausage and meatloaf. The material 
was collected in full for sterile bags and transported to the laboratory under controlled temperature (4° C) during 24 hours.
2. Detection of Salmonella spp.
The detection of Salmonella spp. was made according to the method ISO 6579:2002 on accredited laboratory by IPAC 
(L0352) (10).
3. Serotyping of Salmonella spp.
The serotyping was performed at the National Reference Laboratory according to the methodology of slide agglutination 
and tube. This methodology is described to be unique and not disclosed by the laboratory where it is held, as it is the only 
laboratory at the national level to accomplish the same.
4. Susceptibility to antibiotics
The antimicrobial resistance profile was treated using the disc diffusion method based on NCCLS:M31-A2 (11).
Results
From the four analysed samples, two were 
positive for Salmonella spp (Table 1.). 
Both strains were serotyped (Table 2.).
It was confirmed that it was the same 
serovar and was done the antibiotic sus-
ceptibility profile. The results are present-
ed in Table 3.
Discussion
Processed meat products analyzed were 
produced from portuguese pork meat, 
whose process of fattening, slaughtering 
and butchering was also carried out on 
national territory.
The fact that the same Salmonella serovar 
has been isolated from two different meat 
samples produced in the same produc-
tion line, point out this step as a possible 
common source of contamination and 
suggests that should be an improvement 
in the disinfection scheme and further 
analysis to demonstrate the effectiveness 
of this process which, however, does 
not was held at the express wish of the 
customer.
After identification of Salmonella Buda-
pest, there was a broad literature search 
and wasn´t found any references to this 
serovar in Portugal. For that, INSA was 
personally contacted that confirmed that 
this was the first case of contaminated 
Portuguese meat with Salmonella Buda-
Table 1. Results of Salmonella spp. detection 
Sample 
#
Sample name Method Result Units
1 Dry cured sausage ISO 
6579:2002
Absent in 10g Present/absent 
in 10g2 Black pudding Absent in 10g
3 Fresh sausage Present in 10g
4 Meatloaf Present in 10g
Table 2. Results of the serotyping 
Sample 
#
Sample name Parameter Method Result






Table 3. Antibiotic susceptibility to Salmonella Budapest (S –susceptible; I – 
Intermediate; R- resistant). 
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pest. However, two cases from meat imported from Brazil were previously reported (personal comunication).
To draw the profile of susceptibility to antibiotics confirming that it was a resistant strain to important groups (Table 3).
Conclusion
The presence of one serovar in separate products in the same production line confirms ineffectiveness of the hygiene methods 
and suggests a revision of the HACCP since the presence of Salmonella spp. in meat products disrespects legislation (12).
The appearance of this new serovar in Portugal, confirms the high mobility of bacterial strains so far in the case of Sal-
monella enterica Budapest confined to northern Europe to countries further south. This mobilization may be due to high 
transaction of live animals and carcasses within Europe, especially between countries of Eastern Europe, where traceability 
systems are deficient.
The antimicrobial resistance profile obtained confirms that this is an highly harmful bacterial strain which corroborates the 
fears already shown in other studies that warn of the risk of ineffectiveness of antimicrobial treatments in human nature, 
these strains represent a risk for increasing public health.
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